Clinical Trials Browser

Phase 2 × Withdrawn × FANG vaccine × Clear all

NCT02639234 2017-07-31

Vigil™ + Nivolumab in Advanced Non-Small Cell Lung Cancer

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00343447 2012-05-03

Cyclophosphamide and Rituximab Followed By Vaccine Therapy in Treating Patients With Chronic Lymphocytic Leukemia

Phase 2 Withdrawn

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell